Literature DB >> 11095829

Viral Load Monitoring in HIV Infection.

.   

Abstract

Measurement of HIV-1 viral load is now an accepted part of clinical practice for the determination of clinical prognosis and antiretroviral effectiveness in HIV infection. Consensus guidelines have been published on the appropriate use of this testing. Furthermore, recent advances in molecular technology have improved the sensitivity and reproducibility of viral load assays, and these improved assays have provided new insight into the pathogenesis of HIV disease. This article reviews new issues affecting viral load quantification, including viral subtypes, sex, compartmental differences, and other covariables.

Entities:  

Year:  1999        PMID: 11095829     DOI: 10.1007/s11908-999-0064-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  96 in total

1.  HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.

Authors:  A U Neumann; R Tubiana; V Calvez; C Robert; T S Li; H Agut; B Autran; C Katlama
Journal:  AIDS       Date:  1999-04-16       Impact factor: 4.177

2.  Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection.

Authors:  A E Luque; L M Demeter; R C Reichman
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

3.  Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients.

Authors:  R M Donovan; E Moore; C E Bush; N P Markowitz; L D Saravolatz
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

4.  Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization.

Authors:  M Gottfredsson; G M Cox; O S Indridason; G M de Almeida; A E Heald; J R Perfect
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

5.  Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.

Authors:  S G Deeks; R L Coleman; R White; C Pachl; M Schambelan; D N Chernoff; M B Feinberg
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  Effect of splenectomy on T-cell subsets and plasma HIV viral titers in HIV-infected patients.

Authors:  N F Bernard; D N Chernoff; C M Tsoukas
Journal:  J Hum Virol       Date:  1998 Jul-Aug

7.  A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

Authors:  J S Montaner; P Reiss; D Cooper; S Vella; M Harris; B Conway; M A Wainberg; D Smith; P Robinson; D Hall; M Myers; J M Lange
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

8.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

9.  Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.

Authors:  J Min; D A Katzenstein
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-01       Impact factor: 2.205

10.  HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).

Authors: 
Journal:  AIDS       Date:  1998-03-05       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.